Clinical Trials Directory

Trials / Completed

CompletedNCT05106764

Early Detection of Fabry Disease

Early Detection of Fabry Disease (FD): Using Real-World Data for the Development of Advanced Natural Language Processing Methods: Retrospective Database Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Takeda · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The main aim of this study is early detection of FD using real-world data for the development of advanced natural language processing methods and to develop a predictive algorithm and to measure the performance of the algorithm in identifying participants with FD. This study is about using data from hospital Electronic Health Record database from the last 10 years to describe the ranking of participants with FD using multilevel likelihood ratios and to validate the algorithm using positive controls. No investigational medicinal product or device will be tested in this study. Hospital electronic health record data will be analyzed for a period of up to 6 months.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionThis is non-interventional study.

Timeline

Start date
2023-11-30
Primary completion
2025-12-16
Completion
2025-12-16
First posted
2021-11-04
Last updated
2026-03-16

Locations

3 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT05106764. Inclusion in this directory is not an endorsement.

Early Detection of Fabry Disease (NCT05106764) · Clinical Trials Directory